Introduction
============

The existence of human tick-borne disease (TBD) has been previously described in Australia by the author to comprise multiple zoonoses induced by the pathogens *Borrelia*, *Babesia*, *Bartonella*, *Anaplasma*, and *Ehrlichia* spp.[@b1-ijgm-8-015] Other arbobacteria infections sometimes found worldwide are *Coxiella burnetii*, *Francisella tularensis*, *Yersinia pestis*, and the *Rickettsia* sp., with the latter comprising significant infection on this continent and having three unique subspecies.[@b1-ijgm-8-015] Most grow intracellularly, but *Borrelia* sp. is also extracellular and *Y. pestis* is mainly extracellular.[@b2-ijgm-8-015] In this case series of 500 consecutive patients presenting between October 2010 and February 2014, either referred or self-initiated regarding the possibility of "Lyme disease", an analysis was done to define the clinical characteristics at the time of presentation of these zoonoses compared to those seen in North America, Europe, and Asia, as well as to quantify incidence figures. Patients attended from every state in Australia. In Australia, borrelial infection typically manifests with a neurological presentation, which follows the course seen in Europe and Asia, as discussed earlier.[@b1-ijgm-8-015] Australian endemic human babesiosis with *B. microti* has been reported clinically, serologically, and at the molecular level.[@b1-ijgm-8-015],[@b3-ijgm-8-015],[@b4-ijgm-8-015] There has been a recent nomenclature shift, with this piroplasm now classified as a *Theileria* sp. In this manuscript, the former nomenclature will be used. Babesiosis with *B. duncani* has been previously reported as an Australian endemic infection by this author.[@b1-ijgm-8-015] Herein, the first Australian human endemic Anaplasmataceae infections with *A. phagocytophilum* and *E. chaffeensis* are reported: three cases for the former and one for the latter pathogen. This is intended to show a complex interplay of symptoms and signs between these TBD infections, clinically necessitating a thorough assessment to be able to treat the diseases appropriately. Diagnosing borreliosis has previously been discussed, including the fact that North America singularly has a large proportion of mono or pauci arthritis characterized by extensive swelling, which can be migratory.[@b1-ijgm-8-015] This arthritic presentation is not seen in Australian borreliosis in this series. Also, it is important to reiterate that the involvement of a large number of cranial nerves will point the differential diagnoses at only borreliosis, bartonellosis, sarcoid, and Guillaine Barre disease.[@b1-ijgm-8-015] Amyloid should now be added to this list as a further causative factor, but there also appears to be a strong association with neuroborreliosis and sarcoidosis.[@b5-ijgm-8-015]--[@b13-ijgm-8-015] The patient's clinical history and examination techniques used in diagnosing TBD at a clinical level are discussed and correlated to the level of laboratory-supported diagnosis that can be expected. Particular emphasis is given to diagnosing neuroborreliosis from a clinical perspective. Some early demographic and epidemiological data for this continent are presented.

Materials and methods
=====================

Demographic and epidemiologic assessment
----------------------------------------

The data from 500 patient records were analyzed using 55 parameters that were subdivided into demographic, epidemiological, and clinical findings (see [Tables 1](#t1-ijgm-8-015){ref-type="table"} and [2](#t2-ijgm-8-015){ref-type="table"}). A patient questionnaire was obtained prior to consultation to assess the likelihood of multisystemic disease and multiple cranial nerve abnormality. This was a truncated version of a symptom list from the Burrascano Lyme disease guidelines.[@b14-ijgm-8-015] Inquiry was made into tick attachment and any associated reddening or swelling of the skin. A travel history outside Australia was sought from the perspective of ever going abroad or being born overseas.

Clinical assessment
-------------------

Symptoms and signs of cranial nerve deficit were sought using a cranial nerve assessment tool ([Table 3](#t3-ijgm-8-015){ref-type="table"}). This tool was refined over time. Signs were sought by physical examination. The peripheral nervous system was briefly reviewed, but it was generally not helpful in pinpointing TBD, except that a pathological upwards plantar response (Babinski sign) and hypothenar wasting were not uncommon, which are possible indicators of babesiosis.[@b15-ijgm-8-015] Particular note was made of large joint pain (hip, knee, shoulder, elbow, wrist, and ankle) with or without swelling compared to small joint pain in the hands, feet, spine, and jaw. The costochondral joints were checked for tenderness. Three psychological parameters in particular were sought: panic attacks lasting more than 30 minutes is associated with borreliosis; in addition, sudden bursts of anger and worsening obsessive compulsive behavior are both associated with bartonellosis. Certain investigation parameters were analyzed in three groups with testing performed at Australian Biologics Sydney ([Table 4](#t4-ijgm-8-015){ref-type="table"}), IGeneX at Palo Alto, CA, USA ([Table 5](#t5-ijgm-8-015){ref-type="table"}), and ancillary tests conducted at laboratories across Australia ([Table 6](#t6-ijgm-8-015){ref-type="table"}; this table also shows single-photon emission computed tomography \[SPECT\] scans).

### Borrelia

The patients' symptoms, signs, and examination were checked for neurological problems (as indicated in [Table 3](#t3-ijgm-8-015){ref-type="table"}), as well as for multisystemic problems over the timeline of the disease (as previously discussed) to form a clinical opinion of the likelihood of the disease based on the involvement of more than three cranial nerves and at least one other system.[@b1-ijgm-8-015] The history questionnaire was used to assess patients' symptoms in the first instance in all cases, and some points would require clarification during the consultation, which involved the use of the cranial nerve tool and multisystem review. If the review showed three or fewer cranial nerves involved, then it was determined that borreliosis was a possibility; however, laboratory testing needed to be relied upon for a diagnosis. For more than three cranial nerves involved, a clinical diagnosis of borreliosis or bartonellosis was made. At this juncture, it should also be stated that reliance was placed on a negative computed tomography (CT) or magnetic resonance imaging (MRI) scan of the brain to exclude overt intracranial disease, and this was ordered if not done previously.

### Babesia and Bartonella

Attention was also focused on blocks of symptoms in the patient questionnaire that typically occurred with these TBD coinfections ([Table 7](#t7-ijgm-8-015){ref-type="table"}). The significant presence of more than just a few of these factors in recognized TBD illness is a harbinger for the presence of coinfection based on clinical grounds. Symptoms/signs that may indicate *Babesia* are tinnitus, chills, flushing, dysphagia, severe neurological disease, thirst, night sweats, chest wall or sternal pain, polydipsia, fatigue, severe nausea, malaise, fever, fine hemangiomas, hypothenar atrophy, papular or vesicular rash, petechiae, anemia, abnormal platelet counts, and the development of these symptoms during borreliosis therapy.[@b15-ijgm-8-015],[@b16-ijgm-8-015] Two European reviews are also helpful in understanding this disease from a clinical perspective.[@b17-ijgm-8-015],[@b18-ijgm-8-015] Symptoms/signs that may indicate *Bartonella* are brain fog, ice pick headaches, photophobia, tachycardia, bowel issues, tender subdermal masses (particularly of the neck, forearm, and ileotibial band), increased obsessive compulsive behavior, anxiety, endocarditis, retinitis, peripheral neuropathy, rapid relapse off antibiotics, immediate systemic illness following tick bite (within days), swollen joints, psychiatric issues, costal margin pain and tenderness, rapid mood shifts, and the development of these symptoms during *Babesia* therapy.[@b15-ijgm-8-015],[@b16-ijgm-8-015]

### Anaplasma/Ehrlichia

*A. phagocytophilum* and *E. chaffeensis* are the etiologic causes of anaplasmosis and ehrlichiosis, and they were formerly known as human granulocytic ehrlichiosis and human monocytic ehrlichiosis, respectively, indicating the white cell line implicated in each infection.[@b1-ijgm-8-015] The particular symptoms that may guide the diagnostician with these infections are, myalgia, tendon pain, extreme soft tissue tenderness, right upper quadrant pain, slumped posture, hepatomegaly, diaphoresis, muscle spasms, elevated liver enzymes (intrahepatic pattern) and, most importantly, a depressed white cell count.[@b15-ijgm-8-015],[@b16-ijgm-8-015] Acute infection can be lethal, and treatment must start on clinical suspicion with doxycycline before laboratory confirmation. However, when these TBDs are associated with borreliosis, there appears a much slower chronic and lingering infection with reports of extreme fatigue and feeling severely unwell. With not much in the way of distinctive symptoms, a high degree of suspicion is warranted. Testing is done by serology and polymerase chain reaction (PCR).

#### Other infections

*Mycoplasma pneumoniae* and *Mycoplasma fermentans* will lead to fatigue, fever, insomnia, headache, bowel issues, psychiatric disturbances, and arthritis (both large and small joints) with joint swelling.[@b16-ijgm-8-015] *M. fermentans* can show a negative response to prior antibiotic use with tetracyclines and macrolides. *Chlamydophila pneumoniae*, formerly designated as *Chlamydia pneumoniae* (CPN), is a known cause of respiratory illness, but it may also cause widespread arthritic pains in patients with TBD, as can *C. trachomatis*.[@b19-ijgm-8-015] Of particular note in the current study shows 68% monoarthropathy and 32% polyarthropathy. *M. pneumoniae* and *Chlamydia* serum PCR investigations returned positive findings in spite of negative serology for those infections in the patient series. *Rickettsia* infections sometimes appeared, and they routinely had neither been tested nor treated. Anecdotally, Epstein--Barr virus infection is said to be problematic in the presence of borreliosis and can flare up during treatment. Brucellosis, human herpesvirus 6, human immunodeficiency virus (HIV), leptospirosis, parvovirus, Q fever, and syphilis must be considered when determining the status of the patient, particularly in the context of immune suppression, as will be discussed.

Imaging studies
---------------

Many patients presented with prior brain CT scans and MRIs. When absent, a CT of the brain was ordered. In some patients who appeared to have a greater degree of neurological deficit but normal prior scanning, SPECT CT of the brain was done.

Laboratory assessment
---------------------

Two laboratories capable of extensive investigation of *Borrelia* and other TBD coinfections were used.

### Australian biologics

Australian Biologics Laboratory Testing Services in Sydney, Australia was used initially in the series, and whole blood and serum analyses were performed for the detection of specific *Borrelia* sp. DNA using multiplex PCR for *B. burgdorferi*, *B. afzelii*, and *B. garinii*. Samples were analyzed in duplicate with positive and negative controls using primers AB--B1 (proprietary to Australian Biologics) for the *Borrelia* 16S rRNA gene target. The thermal profile for both analyses involved incubation for 2 minutes at 50°C, polymerase activation for 10 minutes at 95°C, then PCR cycling for 40 cycles of 10 seconds at 95°C, dropping to 60°C sustained for 45 seconds. The positive control used was an American Type Culture Collection (ATCC) *B. burgdorferi* genomic control. The magnitude of the PCR signal generated (∆R) for each sample was interpreted as positive or negative, as compared to positive and negative controls. Validation of the assay was produced firstly by the use of external sequencing, and secondly through participation in quality assurance programs for the detection of *Borrelia* by PCR with Quality Control for Molecular Diagnostics (Glasgow, Scotland, UK), a joint research facility of Glasgow and Strathclyde Universities (Glasgow, Scotland, UK). Later, urine PCR analysis was added. From February 2012, some patients were also investigated by Mikrogen immunoblot for IgM and IgG, and they were also tested for borrelial T-lymphocyte transformation via the enzyme-linked immunosorbent spot test (ELISPOT). This laboratory also offered *M. pneumoniae*, *M. fermentans*, and chlamydophila PCR investigations.

### IGeneX

The other laboratory principally used for borreliosis investigation was IGeneX in Palo Alto, CA, USA. IGeneX also offered testing for *Babesia*, *Bartonella*, *A. phagocytophilum*, and *E. chaffeensis*. IGeneX is a major laboratory specializing in TBDs. It is a reference laboratory recognized by the American College of Pathologists, and it is also Clinical Laboratory Improvement Amendments (CLIA), Medicare, and Medicaid approved, thus satisfying licensing requirements for testing throughout most of the United States to perform highly complex clinical testing.[@b20-ijgm-8-015] The US Food and Drug Administration and Centers for Disease Control and Prevention (CDC) oversee the performance of the CLIA.[@b20-ijgm-8-015] IGeneX has also met licensing requirements for testing in the states that require additional licensing: California; Florida; Maryland; New York; and Pennsylvania. Statements concerning laboratory performance and validation in the area of quality assurance in borreliosis testing are available on the IGeneX Website.[@b21-ijgm-8-015] Collection of sera and timely shipment was previously discussed.[@b1-ijgm-8-015] Sera were analyzed by an immunofluorescent antibody assay (IFA), followed by IgG and IgM Western blot (WB) assays. IGeneX WB uses two different strains B-31 and B-297. OspA and OspB bands are retained in the tests.[@b22-ijgm-8-015] These bands were removed from the CDC reporting criteria because they were used in the Lyme vaccine, LYMErix™. The result is a sensitivity level \>90% for the IGeneX WB test compared to 46% sensitivity for commercial tests.[@b22-ijgm-8-015] Both whole blood and sera were analyzed for the detection of specific *Borrelia* sp. DNA using multiplex PCR testing for *B. burgdorferi*-specific DNA sequences from OspA A plasmid and flagellin genes. The test is not *B. burgdorferi* specific, and it also detects *B. afzelii*, *B. andersoni*, and *B. garinii*. Simultaneously, some patients were tested for *B. microti, B. duncani*, *A. phagocytophilum*, *E. chaffeensis*, and *B. henselae* infection by IgG and IgM IFA serology, PCR, and fluorescent in situ hybridization.

### Other laboratories

Several standard accredited laboratories across Australia were used for CD57 estimation and the several nonborreliosis serologies discussed within.

Results
=======

Demographic and epidemiologic factors
-------------------------------------

The average patient's age at presentation was 41 years, with a median of 42 years and a standard deviation (SD) of 18 years. Refer to [Table 1](#t1-ijgm-8-015){ref-type="table"} and see [Figure 1](#f1-ijgm-8-015){ref-type="fig"} for a rather widely splayed cumulative distribution curve. There were 310 females (62%) in the study. Only 83 of 492 respondents (16.5%) reported never leaving the country. Illness length in years was an average of 7.4, with a maximum of 47 years, a minimum of 0.17 years, a median of 3.0 years, and a SD of 9.5 years from a sample size of 341. The average age of the commencement of illness was therefore 35 years, with a median of 35 years and a SD of 19 years. Thirteen patients' illness could be traced from birth or in the first year of life; six were siblings, two were from one family, and four were from another, indicating the possibility of maternal transmission. In addition, borreliosis was laboratory proven in both mothers. A recognized history of tick bites was found in 240 of 340 individuals (71%), though the time span from bite to illness could not be reliably estimated in the majority of cases.

Clinical findings
-----------------

### Borrelia

Certain clinical parameters are shown in [Table 2](#t2-ijgm-8-015){ref-type="table"}. Of the 240 individuals reporting a tick bite, 108 (22% of the total cohort size) reported an associated rash large enough to have been considered as erythema migrans. Clinically, the diagnostic criterion for this rash is a minimum of 5 cm. Cranial nerve involvement was extensive and is charted as a histogram for each individual nerve ([Figure 2](#f2-ijgm-8-015){ref-type="fig"}). Cranial nerves 5, 8, 10, and 11 were involved in at least 50% of respondents. It was previously proposed that when diagnosing neuroborreliosis clinically, only *Borrelia*, *Bartonella*, sarcoid, amyloid, and Guillain--Barre disease could affect more than two cranial nerves at a time, and that three nerves appear to be a crucial number in this series.[@b1-ijgm-8-015] Involvement of more than three cranial nerves was found in 296 patients (59%), while involvement of more than two cranial nerves was found in 310 patients (62%) (see [Figures 3](#f3-ijgm-8-015){ref-type="fig"}, [4A](#f4-ijgm-8-015){ref-type="fig"}, and [4B](#f4-ijgm-8-015){ref-type="fig"}). The incidence of clinically-supported borreliosis jumps dramatically at the involvement of four cranial nerves (refer to [Table 8](#t8-ijgm-8-015){ref-type="table"} and [Figure 4](#f4-ijgm-8-015){ref-type="fig"}). Cardiac history commonly revealed tachycardia or arrhythmia. All patients presented with electrocardiograms that were already performed to assess for heart block (a known complication of borreliosis), and to determine the baseline QTc for prescribing purposes.[@b23-ijgm-8-015] No incidence of third-degree heart block was found. Seriously delayed QTc was found in only a very small number of patients. There were some patients that were already diagnosed with postural orthostatic tachycardia syndrome (POTS), and adding suspected cases from the patient histories brought that number to 48. Many went on to have a positive tilt table test. POTS is a recognized complication of borreliosis.[@b24-ijgm-8-015],[@b25-ijgm-8-015] Neural involvement with lymphoplasmocellular infiltrates can be found in the autonomic ganglia.[@b26-ijgm-8-015] More centrally, cardiac rhythm has been shown to be controllable from the reticular formation in the midbrain, as well as from the posterior hypothalamus.[@b27-ijgm-8-015] There are no literature reports associating bartonellosis to POTS on a PubMed search. The author, however, suspects this association on the basis of Herxheimer-type reactions (which will be discussed) during initial *Bartonella*-targeted treatment, which is administered prior to borrelial treatment.

In addition to POTS and heart block, borreliosis can cause carditis. A PubMed search for borreliosis + carditis conducted on September 6, 2014 yielded 326 articles. Severe cardiac arrhythmia and arrest has been reported.[@b28-ijgm-8-015]--[@b33-ijgm-8-015] Bartonellosis may cause carditis and also cardiac valvular disease. A PubMed search on the same date for cardiac + bartonellosis + human returned 123 articles.

In the study gastrointestinal symptoms were recorded for nausea, belching, flatus, diarrhea, constipation, and abdominal pain. *Borrelia* may cause bladder dysfunction. A key urinary symptom includes returning immediately after urinating but finding nothing to pass. Skin problems were reported in 11% of the cohort; they were usually widespread and often presented with itching. In 6% of patients, Morgellons could be demonstrated by skin microscopy. Morgellons has recently been closely associated with borrelial infection.[@b34-ijgm-8-015]--[@b37-ijgm-8-015] There was no previous report of the incidence of Morgellons in a large borreliosis population cohort. Moreover, 11% of patients presented with small joint pain. Most often, one had to see which treatment worked best to abate this symptom to be sure of its diagnostic etiology. The two patients with large joint pains had returned from living in the US where they had contracted and undergone treatment for their infection. Using cranial nerve criteria of the involvement of more than three cranial nerves, there was a clinical diagnosis of borreliosis in 296 individuals and laboratory proof in 158 of those cases.

### Babesiosis

Examining the possible constellation of symptoms and signs with respect to babesiosis there were 268 cases clinically suspected and 46 laboratory proven. The babesiosis figures can be further subdivided into infection by *B. microti* (number \[n\]=13) and *B. duncani* (n=33), respectively, from 123 patients; four individuals had both simultaneously. These coinfections are more difficult to prove.

### Bartonella

For bartonellosis, when examining the possible constellation of specific symptoms and signs, it was found that there were 240 clinically-suspected cases and 23 laboratory-proven cases. With *Bartonella*, we suspect that there is more than the genus *B. henselae* involved, which is the only one tested in this series. In Australia, *B. koehlerae* has been reported to cause human disease.[@b38-ijgm-8-015] *B. bacilliformis*, *B. quintana*, and *B. vinsonii* subspecies *berkhoffii* are known to cause human disease as well.[@b39-ijgm-8-015]--[@b42-ijgm-8-015] Similarly, it is suspected that in Australia, there are other *Babesia* sp. causing human infection, and *B. divergens* is known to cause human disease.[@b40-ijgm-8-015]

Combined symptomatology of the two coinfections, as well as borreliosis alone, was found in 307 (61%) individuals. Finally, by aligning the data for clinical and laboratory factors for all three infections, only 50 (10%) individuals in the entire cohort had no diagnosis. This assumes that *Babesia* and *Bartonella*, where they had occurred, were transmitted with borreliosis as a TBD. For *Bartonella*, this is not necessarily true, and among the case load there were two incidences of pure *Bartonella* infection, requiring only *Bartonella*-targeted treatment to achieve full recovery.

#### Other infections

Clinical factors for other infections were not reliably recorded in the individual files.

Laboratory findings
-------------------

The specific methods of laboratory testing for borreliosis, bartonellosis, babesiosis, *Anaplasma*, and *E. chaffeensis* have been previously discussed.[@b1-ijgm-8-015] Results showing the incidence of the respective findings are set out in [Table 4](#t4-ijgm-8-015){ref-type="table"} for Australian Biologics; of note, 127 of 216 individuals were borreliosis positive (59%). In [Table 5](#t5-ijgm-8-015){ref-type="table"}, which presents data for IGeneX, it was found that 146 of 252 individuals were borreliosis positive (58%). Also, IGeneX testing showed that 66 of 123 individuals were positive for *Babesia* (54%), 29 of 122 were positive for *Bartonella* (24%), eight of 26 were positive for anaplasmosis (31%), and five of 26 were positive for *E. chaffeensis* infection (19%). A review of the sequencing information of the data from Australian Biologics showed that the following species were found: *B. burgdorferi* CA382; N40; ZS7; *B. garinii*; *B. afzelii*; and *B. valaisiana*. The initial CD57 count was assessed in 418 individuals; the average was 78. Three were as low as zero. Normal is considered higher than 110.

Imaging
-------

Invariably, CT and MRI were normal, except that occasionally an MRI brain scan would report flecks or spots of white in white matter, which were dismissed as unimportant, incidental, or of no clinical significance. SPECT CT of the brain is a valuable method for documenting the degree of neuroborreliosis.[@b43-ijgm-8-015] Fifty-five patients underwent the procedure. Some sites in Australia reliably reported the defects of this disease as neuroborreliosis. Other sites reported defects, but they dismissed these as nonspecific, in spite of the diagnosis on the request form. A review of the patient data indicated that 40 scans (73%) showed regional defects in perfusion, as reported by radiologists, with some reports confirming neuroborreliosis.

*Anaplasma Ehrlichia* infection case reports
--------------------------------------------

Many patients were tested by serology and PCR for *A. phagocytophilum* and *E. chaffeensis* in Australia with completely negative results. Recently, the author requested this testing from IGeneX, and positive results were obtained again. Eight patients had *Anaplasma* infection and five had *E. chaffeensis* infection. Importantly though, four very sick individuals were found: one with *E. chaffeensis* and three with *Anaplasma*; these patients had never left Australia. This becomes the first case report of endemic human infection in Australia with these two bacteria. Two had low white cell counts of 3.4 and 2.9 by 10^9^/L, respectively. All four were markedly intolerant of doxycycline and had to start 50 mg doses, which slowly increased incrementally. All had laboratory-proven coexistent borreliosis, indirectly providing evidence for tick transmission.

Rickettsial infections
----------------------

Of the 500 patients in this study, 30 of 279 (11%) individuals had positive rickettsial serology (either IgM or IgG), demonstrating past or present infection. Allowing for some degree of cross-reactivity, this is still an appreciable number.

Other parameters
----------------

Other factors known to suppress the immune system in borrelial infection are the administration of cortisone and chemotherapy.[@b44-ijgm-8-015],[@b45-ijgm-8-015] Many coexisting infections are found in borreliosis, the incidence of which is reported in [Table 6](#t6-ijgm-8-015){ref-type="table"}. *C. pneumoniae* testing by serology was positive in 48 out of 152 individuals and by PCR in nine out of 50 individuals on serologically-negative patients. Serology detected that 44 of 174 individuals were positive for *M. pneumoniae*, while PCR detected that 30 out of 65 were positive among serologically-negative patients. *M. fermentans* by PCR detected 18 positives out of the 69 tested. Other infections that were screened for included Q fever, brucellosis, leptospirosis, and HIV; viral encephalopathies may need to be considered.[@b46-ijgm-8-015]

Discussion
==========

Distinguishing between borreliosis and bartonellosis in a clinical setting is extremely difficult, and reliance on specific *Bartonella* symptoms is important. It appears that both diseases often coexist and are tick-borne in Australia. A comparison can be made with a recent publication by Berghoff [@b47-ijgm-8-015] on the differential diagnoses of these infections. There is a wide age distribution and, importantly, an extensive delay in the recognition and diagnosis of neuroborreliosis. This could be improved with detection of cranial nerve symptoms and deficits. The cumulative histogram in [Figure 4](#f4-ijgm-8-015){ref-type="fig"} shows, firstly, an exponential increase in the clinical diagnosis of neuroborreliosis with increasing cranial nerve involvement and, secondly, the number of positive laboratory findings that rise correspondingly with the involvement of four cranial nerves. The histograms show a sigma curve, which is virtually identical for both a clinical diagnosis versus a laboratory-supported diagnosis. When examining the figures for a clinical diagnosis, the X-axis simply represents an ordinal increase in count and the gradient (tan θ) is simply the difference between each Y-axis count: 14 for 3; 43 for 4; 55 for 5; 51 for 6; and 69 for 7, before falling again as the sigma curve flattens. Linear regression analysis of the data yielded a coefficient of 0.999485. It is proposed that the involvement of three cranial nerves is thus a critical number, which could pivot the diagnosis of clinical borreliosis or bartonellosis in either direction; however, the involvement of four or more cranial nerves correlates well with a clinical diagnosis of either borreliosis or bartonellosis.

The ELISA/IFA/WB controversy has been discussed before.[@b1-ijgm-8-015] The current CDC position statement on Lyme disease case surveillance can be found on the CDC Website.[@b48-ijgm-8-015] It has been acknowledged by the CDC that there is a large burden of disease that can only be diagnosed clinically. Specifically, the CDC states the following "For purposes of surveillance":[@b48-ijgm-8-015] "Nervous system. Any of the following, alone or in combination: lymphocytic meningitis; cranial neuritis, particularly facial palsy (may be bilateral); radiculoneuropathy; or, rarely, encephalomyelitis."

In this report, there is very close concordance between the sensitivities of IGeneX and Australian Biologics running at 58% and 59% of the total tested, respectively. In Europe borreliosis is associated sometimes with acrodermatitis chronica atrophicans which is caused by *B. afzellii*. In this series, only two patients had acrodermatitis chronica atrophicans and one had never traveled outside Australia. Diagnosing the correct infections to prioritize appropriate treatment is essential. It is important to clear coinfections before treating infections caused by *Borrelia*.[@b15-ijgm-8-015],[@b16-ijgm-8-015] Treating *Borrelia* infections first can, in fact, make the patient deteriorate further.[@b15-ijgm-8-015],[@b16-ijgm-8-015] This is supported by observation of the emergence of the specific coinfection symptoms of bartonellosis or babesiosis during borreliosis treatment. Not only must the two coinfections be cleared, but any of the other current infections should also be treated, and sometimes this can be viral. A quick check on the CD4 count will tell if the patient is fighting a viral load. Almost surprisingly, the incidence of HIV positivity in the cohort was zero where tested. As can be seen by the data presented, pure borrelial infection is not common in Australia, and consideration must be given to a host of infections when assessing TBD. The data were reliable for this finding from patient 300 onwards. In this subset, 17 (8.5%) patients had pure borreliosis confirmed by testing, and no clinical suspicion or laboratory proof of coinfection was observed. Fifty patients (10%) could not be diagnosed as having one of the three key infections in the series, either clinically or by investigation. It is highly concerning that 11% of patients had positive rickettsial serology with a protracted disease complex and had never been tested for this infection.

White matter flecks seen on MRI in proven neuroborreliosis can be a result of that infection.[@b49-ijgm-8-015]--[@b52-ijgm-8-015] Further, Kanekar and Devgun[@b53-ijgm-8-015] state that in neuroborreliosis, "The most common abnormality seen on MR is multiple bilateral periventricular and/or subcortical foci of T2 prolongation. These findings usually mimic MS (multiple sclerosis); however, multiple enhancing cranial nerves (third, fifth, and seventh cranial nerve), nerve root, or meningeal enhancement may favor Lyme over MS.[@b43-ijgm-8-015],[@b53-ijgm-8-015]--[@b56-ijgm-8-015]"

The incidence of SPECT abnormality in neuroborreliosis was 75% in one study.[@b43-ijgm-8-015] The current study's data of 40 out of 55 scans (73%) appear to conform to those findings if the reported areas of reduced perfusion are considered as an abnormal scan. CD57 is a measure of immune suppression in the presence of borreliosis;[@b57-ijgm-8-015] normal is considered a value ≥110 cells/mm^3^ using the Beckman Coulter antibody (catalog A74779; Beckman Coulter, Inc., Brea, CA, USA), with \<60 considered very significant borreliosis. The potential diversity of tick-borne infections was recently enumerated at 237 pathogens in a recent study of *Ixodes perscultatus* in the People's Republic of China;[@b58-ijgm-8-015] this has modeling applications for Australia.

Jarisch--Herxheimer reaction
----------------------------

This reaction is well described in the literature, but particularly well by Horowitz.[@b16-ijgm-8-015] In summary, the breakdown products of the cellular components of *Borrelia*, *Babesia*, and *Bartonella* (in particular, the cell wall products of *Borrelia*) produce a temporary IL storm of IL-1, IL-6, and TNF-α. The effect is similar to having viral influenza, which induces the same storm, plus a patient will experience some of the symptom set associated with their own disease complex. The reaction can be very severe in some individuals and is dependent upon bacterial load versus treatment dosage. In treatment, a balance is sought between what a patient can comfortably endure using as many remedial measures as possible to relieve distress, and sufficient therapy to be effective against the disease being targeted.

The vectors
-----------

Recently Mayne et al have unequivocally demonstrated evidence for *Ixodes holocyclus*, the paralysis tick, as a vector for human borreliosis.[@b59-ijgm-8-015] The vector is found along the entire eastern seaboard of the continent and across into central Victoria. Other vectors need to be sought in this region and across Australia.

Conclusion
==========

Neuroborreliosis can affect large numbers of cranial nerves. Herewith, data were presented demonstrating that a thorough search for symptoms and signs of cranial nerve abnormality can clinically pinpoint neuroborreliosis and/or bartonellosis when more than three nerves are involved. The total results highlight an underestimated set of TBD in Australia that requires further research and evaluation. Borreliosis is protean in its manifestation and difficult to treat if protracted. Those in the medical profession in Australia need to be alert to the possibility of detecting this disease and its associated coinfections early to initiate effective short-lasting treatment, thus preventing a cascade into severe chronic borreliosis, which can be devastating in all aspects of life.
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![Histogram of the incident of involvement for each cranial nerve.](ijgm-8-015Fig2){#f2-ijgm-8-015}

![Histogram showing the incidence of the total number of cranial nerves involved in the dataset (red) and respective laboratory proof of borreliosis (green).](ijgm-8-015Fig3){#f3-ijgm-8-015}

![Cumulative involvement of the cranial nerves by total and laboratory-proven borreoliosis by cranial nerve involvement.\
**Notes:** (**A**) Cumulative involvement of the cranial nerves by total; (**B**) laboratory-proven borreoliosis by cranial nerve involvement.](ijgm-8-015Fig4){#f4-ijgm-8-015}

###### 

Demographic and epidemiologic parameters extracted from the dataset

  Demographic, epidemiologic, and clinical parameters       Number   Percentage   Total number
  --------------------------------------------------------- -------- ------------ --------------
  Average age at presentation                               41                    500
  Average age at onset of illness                           35                    500
  Sex, female                                               310      62           500
  Never left the country                                    83       17           492
  Average illness length in years at time of presentation   7.4                   343
  Tick bites recorded                                       240      71           340

###### 

Clinical parameters extracted from the dataset

  Clinical parameters extracted from the dataset                    Incidence   Percentage   Number
  ----------------------------------------------------------------- ----------- ------------ --------
  EM rash adequately described                                      108         78           139
  Cranial nerve dysfunction                                         355         71           500
  More than three cranial nerves involved                           296         59           500
  Cardiac problem of any description                                52          58           89
  Suspected postural orthostatic tachycardia syndrome               48          54           89
  Gastrointestinal symptoms of any kind                             80          52           153
  Genitourinary symptoms                                            68          44           153
  Dermopathy of any type                                            55          36           153
  Morgellons evidenced by direct skin microscopy                    29          6            500
  Small joint pain                                                  57          37           153
  Large joint pain                                                  2           1            153
  Mono arthritis (documented illness in the United States)          2           0            500
  Clinical borreliosis -- more than three cranial nerves involved   307         61           500
  Clinical babesiosis -- specific babesiosis symptoms               268         92           292
  Clinical bartonellosis -- specific bartonellosis symptoms         240         89           270

**Abbreviation:** EM, erythema migrans.

###### 

Cranial nerve assessment tool for neuroborreliosis and bartonellosis

  Cranial nerve   Reported symptoms                                 Examination
  --------------- ------------------------------------------------- ----------------------------------------------------------------
  1               Phantom smells                                    Anosmia partial/full
  1               Any loss of smell                                 
  1               Left or right                                     Which side
  2                                                                 Visual acuity
  2               Loss of any part of vision                        Visual fields
  2               Any floaters                                      Check patient's understanding
  2               Any loss of night vision                          
  3                                                                 Full pupil assessment
  3                                                                 Focusing difficulty with small print
  3               Dilated pupil(s)                                  
  3               Double vision -- directional                      Diplopia -- medial or upwards
  3               Drooping eyelids                                  Ptosis
  4               Double vision -- downwards direction              Diplopia -- downwards direction
  6               Double vision -- lateral with weak affected eye   Diplopia -- lateral with weak affected eye
  5               Facial pain                                       Facial pain trigeminal divisions
  5                                                                 Loss of corneal reflex
  5               Taste changes                                     
  5               Dental pain                                       
  5               Jaw pain                                          
  7               Facial paralysis (Bell's palsy)                   Facial paralysis (Bell's palsy)
  7               Facial muscle weakness or muscle twitching        Facial muscle weakness or muscle twitching
  7                                                                 Test masseters
  7                                                                 Mental reflex
  8               Loss of hearing during illness                    
  8               More sensitive to loud sound or pain              
  8               Tinnitus                                          Tinnitus
  8               Vertigo                                           Vertigo, check on true meaning
  8               Imbalance                                         Imbalance
  8                                                                 Rombergism
  8                                                                 Nystagmus (rapid is affected side)
  9               Throat sore                                       
  9               Difficulty swallowing                             
  9                                                                 Elevates larynx swallowing
  9                                                                 Gag reflex present
  9               Lack of saliva                                    
  10              Neck pain around the throat                       
  10              Slurring of speech                                Slurring of speech
  10              Mispronunciation                                  Mispronunciation
  10              Rapid beating of the heart or irregularity        Rapid beating of the heart or irregularity standing up quickly
  10              Feeling faint                                     Feeling faint
  10                                                                Clinical evidence or suggestion of POTS
  11              Cannot shrug shoulders                            
  11                                                                SCM and trapezius strength
  12              Difficulty with tongue movements                  Tongue movement and strength full
  12              Biting tongue                                     

**Abbreviations:** POTS, postural orthostatic tachycardia syndrome; SCM, sternocleidomastoid.

###### 

Borreliosis and coinfection investigation parameters extracted from the data for AB

  AB testing                             Positives   Percentage   Number
  -------------------------------------- ----------- ------------ --------
  ***Borrelia***                                                  
  Whole-blood PCR                        81          55           146
  Serum PCR                              18          58           31
  Urine PCR                              46          84           55
  Immunoblot IgM                         7           47           15
  Immunoblot IgG                         4           27           15
  Total immunoblot positive              10          67           15
  ELISPOT LTT                            16          84           19
  AB *Borrelia* total positive testing   127         59           216
  AB *Borrelia* total negative testing   89          41           216
  Mycoplasma PCR positive                30          43           69
  Mycoplasma fermentans PCR positive     18          26           69
  AB *Chlamydia* Pn PCR positive         9           18           50

**Abbreviations:** AB, Australian Biologics; PCR, polymerase chain reaction; Ig, immunoglobulin; ELISPOT, enzyme-linked immunosorbent spot test; LTT, lymphocyte transformation test; Pn, *pneumonia*.

###### 

Borreliosis and coinfection parameters from IGeneX data

  Investigation parameters at IGeneX           Positives   Percentage   Number
  -------------------------------------------- ----------- ------------ --------
  ***Borrelia***                                                        
  IFA                                          19          95           20
  PCR serum                                    18          60           30
  PCR blood                                    9           43           21
  Western blot IgM                             93          79           117
  Western blot IgG                             71          69           103
  IGeneX *Borrelia* total testing positive     146         58           252
  IGeneX *Borrelia* total testing negative     106         42           252
  ***Babesia***                                                         
  *Babesia duncani* serology                   43          35           123
  *Babesia microti* serology                   18          15           123
  PCR *Babesia*                                1           1            123
  FISH *Babesia*                               5           4            123
  IGeneX *Babesia* total testing positive      66          54           123
  ***Bartonella***                                                      
  *Bartonella* sero                            23          19           122
  *Bartonella* PCR                             0           0            122
  *Bartonella* FISH                            6           5            122
  IGeneX *Bartonella* total testing positive   29          24           122
  Anaplasmosis                                 8           31           26
  *Ehrlichia chaffeensis*                      5           19           26

**Abbreviations:** IFA, immunofluorescent antibody assay; PCR, polymerase chain reaction; Ig, immunoglobulin; FISH, fluorescence in situ hybridization.

###### 

Other investigations

  Other investigations                                         Incidence   Percentage   Number
  ------------------------------------------------------------ ----------- ------------ --------
  Abnormal CT SPECT brain from 55 requests                     40          73           55
  *Chlamydia* Pn serology positive (positive for IgG or IgM)   48          32           152
  *Mycoplasma* sero (positive for IgG or IgM)                  44          25           174
  EBV sero (positive for IgG or IgM)                           140         89           158
  *Rickettsia* sero (positive for IgG or IgM)                  30          11           279
  Initial CD57 number assessed                                 418                      
  Average CD57 count                                           78                       

**Abbreviations:** CT, computed tomography; SPECT, single-photon emission computed tomography; Pn, *pneumonia*; Ig, immunoglobulin; EBV, Epstein--Barr virus.

###### 

Coinfection questionnaire assessment tool for *Babesia* and *Bartonella*

  ----------------------------------------------------------------------------------------------------------------
  Fevers at night[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Saturated bed clothing from sweating[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Chest wall pain[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Sternum central chest pain[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Shortness of breath air hunger[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Headache at the top of the head or crown[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Dark urine[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Cough chronic and dry excessive bruising[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Vivid dreaming[\*](#tfn6-ijgm-8-015){ref-type="table-fn"}
  Small joint pains[\*\*\*](#tfn8-ijgm-8-015){ref-type="table-fn"}
  Fevers in morning[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Tender lumps under skin[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Electric shocks in limbs[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Skin stretch marks[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Glands swollen -- particularly neck[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Ice pick headaches[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Irritability[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Angry outbursts[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  Pain or soreness in the soles of the feet when getting out of bed[\*\*](#tfn7-ijgm-8-015){ref-type="table-fn"}
  ----------------------------------------------------------------------------------------------------------------

**Notes:**

*Babesia*;

*Bartonella*;

both.

###### 

Incidence and cumulative data for the cranial nerves with laboratory proof

  -------------------------- --- ---- ---- ---- ----- ----- ----- ----- ----- ----- ----- -----
  Cranial nerve              1   2    3    4    5     6     7     8     9     10    11    12
  Incidence of involvement   8   21   14   43   55    51    69    49    24    2     1     2
  Cumulative count           8   29   43   86   141   192   261   310   334   336   337   339
  Laboratory confirmed       6   12   3    21   32    23    37    27    16    1     0     1
  Cumulative count           6   18   21   42   74    97    134   161   177   178   178   179
  -------------------------- --- ---- ---- ---- ----- ----- ----- ----- ----- ----- ----- -----
